SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

What symbol and exchange does Scynexis shares trade?

Scynexis trades on the NASDAQ stock market under the symbol SCYX.

What is Scynexis stock price doing today?

As of October 30, 2026, SCYX stock price declined to $3.77 with 117,757 million shares trading.

What is Scynexis's Beta?

SCYX has a beta of 1.18, meaning it tends to be more sensitive to market movements. SCYX has a correlation of 0.04 to the broad based SPY ETF.

How much is Scynexis worth?

SCYX has a market cap of $37.51 million. This is considered a Sub-Micro Cap stock.

How much money does Scynexis make?

Last quarter Scynexis reported $235,000 in Revenue and -$.57 earnings per share. This beat revenue expectation by $154,670 and missed earnings estimates by -$.08.

What is the highest and lowest price Scynexis traded in the last 3 year period?

In the last 3 years, SCYX traded as high as $24.56 and as low as $3.53.

What are the top ETFs holding Scynexis?

The top ETF exchange traded funds that SCYX belongs to (by Net Assets): VTI, VXF, BSVO, DFAS, DFMC.

Is Scynexis (SCYX) a good investment?

SCYX has underperformed the market in the last year with a return of -31.4%, while the SPY ETF gained +12.3%. In the last 3 month period, SCYX fell short of the market, returning +1.1%, while SPY returned +2.1%. However, in the most recent 2 weeks SCYX has outperformed the stock market by returning +2.7%, while SPY returned -1.0%.

What are the support and resistance levels for Scynexis (SCYX)?

SCYX support price is $3.67 and resistance is $4.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCYX shares will trade within this expected range on the day.